|
Dec. 04, 2020 |
|
|
Dec. 24, 2023 |
|
|
jRCT2052200091 |
Exploratory clinical trail of HANZ to evaluate the efficacy and safety. |
|
Clinical trail of HANZ to evaluate the efficacy and safety. |
TANAKA Hiroyuki |
||
Osaka University Hospital |
||
2-15, Yamadaoka, Suita, Osaka |
||
+81-6-6879-5111 |
||
tanahiro-osk@umin.ac.jp |
||
Development Division I |
||
Nippon Zoki Pharmaceutical Co.,LTD |
||
2-3, Hiranomachi, 4-chome, Chuo-ku, Osaka |
||
+81-6-6203-0455 |
||
clindev-md@nippon-zoki.co.jp |
Complete |
Dec. 01, 2020 |
||
| Jan. 18, 2021 | ||
| 33 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
treatment purpose |
||
(Carpal tunnel surgery) |
||
(Carpal tunnel surgery) |
||
| 20age old over | ||
| No limit | ||
Both |
||
Carpal tunnel surgery due to carpal tunnel syndrome. Nerve suturing due to finger nerve rupture. |
||
In carpal tunnel surgery, HANZ01 is partially covered or wrapped around the peripheral nerve that has opened the nerve strangulation site. In nerve suturing, HANZ01 is wrapped around the peripheral nerve where the torn finger nerve is sutured. |
||
Efficacy |
||
| Nippon Zoki Pharmaceutical Co.,LTD |
| Toyonaka Municipal Hospital Institutional Review Board | |
| 4-14-1, Shibahara-cho, Toyonaka, Osaka | |
+81-6-6843-0101 |
|
| Approval | |
Nov. 04, 2020 |
No |
none |